Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma
Clinical trial NCT04987203 · COMPLETED
Trial details
- NCT number
- NCT04987203
- Sponsor
- AVEO Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-09
- Primary completion
- 2026-01-20
- Enrollment
- 343
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.